Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 15.95 USD -2.92%
Market Cap: 1.5B USD
Have any thoughts about
Arcus Biosciences Inc?
Write Note

Arcus Biosciences Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arcus Biosciences Inc
Other Long-Term Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Arcus Biosciences Inc
NYSE:RCUS
Other Long-Term Assets
$75m
CAGR 3-Years
90%
CAGR 5-Years
172%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Long-Term Assets
$8.3B
CAGR 3-Years
20%
CAGR 5-Years
44%
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Other Long-Term Assets
$7.2B
CAGR 3-Years
15%
CAGR 5-Years
10%
CAGR 10-Years
23%
Amgen Inc
NASDAQ:AMGN
Other Long-Term Assets
$10.4B
CAGR 3-Years
18%
CAGR 5-Years
43%
CAGR 10-Years
21%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Long-Term Assets
$3.3B
CAGR 3-Years
50%
CAGR 5-Years
17%
CAGR 10-Years
96%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Long-Term Assets
$4.1B
CAGR 3-Years
70%
CAGR 5-Years
34%
CAGR 10-Years
31%

See Also

What is Arcus Biosciences Inc's Other Long-Term Assets?
Other Long-Term Assets
75m USD

Based on the financial report for Sep 30, 2024, Arcus Biosciences Inc's Other Long-Term Assets amounts to 75m USD.

What is Arcus Biosciences Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
172%

Over the last year, the Other Long-Term Assets growth was -31%. The average annual Other Long-Term Assets growth rates for Arcus Biosciences Inc have been 90% over the past three years , 172% over the past five years .

Back to Top